Histological Localization of Advanced Glycosylation End Products in the Progression of Diabetic Nephropathy

Nephron

Volumn 76, Issue 2, 1997, Pages 153-160

  Imai, Naofumi ^a   Nishi, Shin Ichi ^a   Suzuki, Yoshiki ^a   Karasawa, Ryou ^a   Ueno, Mitsuhiro ^a   Shimada, Hisaki ^a   Kawashima, Shinji ^a   Nakamaru, Tsukasa ^a   Miyakawa, Yoshikazu ^a   Araki, Norie ^b   Horiuchi, Seikoh ^b   Gejyo, Fumitake ^c   rakawa, Masaaki A ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Advanced glycosylation end products (AGEs); Diabetic nephropathy; Immunohistochemistry

Indexed keywords

GLYCOSYLATED PROTEIN; HYALIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTERIOLE; ARTERY WALL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEINURIA;

EID: 0030966518     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190163     Document Type: Article

References (44)

1. Maillard LC: Actions des acidcs amines sur les sucres: formation des melanoi’dincs par voie mclhodiquc., C R Acad Sci 1912:154:66-68.
2. Brownlee M, Vlassara H, Cerami A: The pathogenetic role of nonenzymalic glycosylation in diabetic complications; in Crabbc MJC (cd): Diabetic Complications: Scientific and Clinical Aspects., London, Churchill Livingstone., 1987., p 94.
3. Njoroge FG., Sayre IM, Monnier VM: Detection of O-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions., Carbohydr Res 1987; 167:211-220.
4. Sell DR., Monnier VM: Structure elucidation of a senescence cross-link front human extracellular matrix J Biol Client 1989:264:21597-21602.
5. Nakamura K., I lascgawa T, Fukunaga Y., Iena-ga K: Crosslines A and B as candidates for the fluorophores in age-and diabetes-related cross-linked proteins, and their diacctatcs produced by Maillard reaction of u-N-acctyl-L-lysine with 7-glucose., J Client Soc Client Commun 1992:14:992-994.
6. Deckcrt T., Poulsen JI: Diabetic nephropathy: Fault or destiny? Diabetologia 1981:21:178-183.
7. Brownlee M., Cerami A., Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications., N Engl J Med 1988:318:1315-1321.
8. Cudvorth AG, Bodansky HJ, West KM: Genetic and metabolic factors in relationship to the prevalence and severity of diabetic complications: in Keen H, Jarretl J (eds): Complications of Diabetes, ed 2., London., Edward Arnold, 1992., p 1
9. Monnier VM., Vishwanath V, Frank KE, El-mets CA., Dauchol P., Kohn RR: Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence., N Engl J Med 1986:314:403-408.
10. Monnier VM, Sell DR, Nagaraj RH., Miyata S, Grandhec S, Odetti P., Ibrahim SA: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes., aging and uremia., Diabetes 1992:41 (suppl 2):36-4l.
11. Makila Z., Vlassara H, Cerami A., Bucala R: Immunochemical detection of advanced glyco-sylation end products in vivo., J Biol Client 1992;267:5133-5138.
12. Makita Z, Vlassara H, Rayficld E., Cartwright K., Friedman E, Rodby R, Cerami A, Bucala R: Hemoglobin AGE: A circulating marker of advanced glycosylation., Science 1992:258:651-653.
13. Yamada K, Miyahara Y., Ilamaguchi K., Nakayama M., Nakano H., Nozaki O., Miura Y., Suzuki S, Tuchida H, Mimura N, Araki N, Floriuchi S: I mniunoh istochcm ical st udy of h u-man advanced glycosylation end-products (AGE) in chronic renal failure., Clin Nephrol 1994;42:354-361.
14. Gugliucci A, Bendavan M: Reaction of advanced glycation endproducts with renal tissue from normal and strcptozolocin-induccd diabetic rats: An ultrastructural study using colloidal gold cytochemistry., J istochcm 1995;43: 591-660.
15. Miyata S, Monnier VM: Immunohistochemi-cal detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline., J Clin Invest 1992:89: 1102-1112.
16. Nishino T, Horii Y., Shiiki H., Yamamoto H., Makita Z, Bucala R., Dohi K: Immunohisto-chcmical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy., Hum Pathol 1995;26:308-313.
17. Makino H., Shikata K., Hironaka K., Hushiro M., Yamasaki Y, Sugimoto FI., Ota Z, Araki N., Floriuchi S: Ultrastructure of nonenzymatical-ly glycated mesangial matrix in diabetic nephropathy., Kidney Int 1995:48:517-526.
18. Suzuki D., Yagame M., Naka R., Jindc K., Endoh M., Nomolo Y., Sakai II., Araki N., Floriuchi S: Immunohistochemical staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin-dependent diabetes mcllitus using monoclonal antibody to advanced glycation end products., Nephrology 1995:1:199-205.
19. Mogensen CE., Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients., N Engl J Med 1984:311:89-93.
20. Floriuchi S., Araki N, Morino Y: Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: Evidence for the presence of a common structure., J Biol Chem 1991;266:7329-7332.
21. Nakayama H, Mitsuhashi T., Kuwajima S, Aoki S, Kuroda Y, Itoh T, Nakagawa S: Immunochemical detection of advanced glycation end products in lens crystallins from streptozo-tocin-induccd diabetic rat., Diabetes 1993:42: 345-350.
22. Monnicr VM, Ccratni A: Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins., Science 1981;211:491-493.
23. Oimomi M., Maeda Y., Hata F, Kitamura Y, Matsumoto S, Baba S., Iga T., Yamamoto M: Glycation of cataraetous lens in non-diabetic senile subjects and in diabetic patients., Exp Eye Res 1988:46:415-420.
24. Nishimoto S, Oimomi M., Baba S: Glycation of collagen in the aorta and the development of aging., Clin Chim Acta 1989;182:235-237.
25. Lyons TJ, Bailie KE., Dyer DG., Dunn JA., Baynes JW: Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mcllitus., J Clin Invest 1991;87:1910-1915.
26. Odetti P, Fogarty J, Sell DR, Monnier VM: Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects., Diabetes 1992;41:153-158.
27. Hayase F., Nagaraj RH., Miyata S, Njoroge FG, Monnier VM: Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo., J Biol Chcm 1989:263:3758-3764.
28. Araki N, Ucno N, Chakrabarti B, Morino Y., Floriuchi S: Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging., J Biol Chcm 1992:267:10211-10214.
29. Miyata S., Perry G., Monnicr VM: Pyrraline., an advanced glvcosylation cndproduct, in basement membrane and plasma: Probing with monoclonal antibody., Diabetes 1990: 39(suppl 1):30A.
30. Mitsuhashi T, Nakayama H, Itoh T., Kuwajima S, Aoki S, Atsumi T., Koike T: Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat., Diabetes 1993;42:826-832.
31. Miyata T, Oda O., Inagi R, lida Y, Araki N, Yamada N., Floriuchi S., Taniguchi N, Maeda K, Kinoshita T: a-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis., J Clin Invest 1993:92:1243-1252.
32. Schnider SI., Kohn RR: Glycosylation of human collagen in aging and diabetes mellitus., J Clin Invest 1980:66:1179-1191.
33. Schnider SI., Kohn RR: Effects of age and diabetes mcllitus on the solubility and nonenzymatic glycosylation of human skin collagen., J Clin Invest 1981:67:1630-1635.
34. Schnider SL, Kohn RR: Effects of age and diabetes mcllitus on the solubility of collagen from human skin, tracheal cartilage and dura mater., Exp Gerontol 1982:17:185-194.
35. llascgawa G., Nakano K., Sawada M., Uno K., Shibayama Y., lenaga K., Kondo M: Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy., Kidney Int 1991;40:1007-1012.
36. Vlassara H, Brownlee M., Cerami A: High-affinity-receptor-mediated uptake and degradation of glucose-mediated proteins: A potential mechanism for the removal of senescent macromolecules., Proc Natl Acad Sci USA 1988:82:5588-5592.
37. Ahmed MU, Thorpe SR., Baynes JM: Identification of carboxvmcthyllysinc as a degrada-tiohr product of fructosyllysine in glycated protein., J Biol Chcm 1986:261:4889-4894.
38. Garlick RL., Mzur JS: The principal site of nonenzymatic glycosylation of human scrum albumin in vivo., J Biol Chcm 1983:258:6142-6146.
39. Iberg N, Fluckiger R: Non-enzymatic glycosylation of albumin in vivo., J Biol Client 1986; 261:13542-13545.
40. Esposito C, Gerlach H, Brett J, Stem D., Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties J Exp Med 1989:170:1387-1407.
41. Dubick MA, Rucker RB., Cross CE., Last JA: Elastin metabolism in rodent lung., Biochim Biophys Acta 1981 672:303-306.
42. Suzuki Y:Constituents of the cxtra ccllularma-triccs in diabetic glomerulosclerosis., Jpn J Nephrol 1989:31:1047-1054.
43. Woessner JF Jr: Matrix metalloproteinascsand their inhibitors in connective tissue remodeling., FASEBJ 1991:5:2145-2154.
44. McVcrry BA., Flopp A., Fisher C., Huehns ER: Production of pseudodiabetic renal glomerular change in mice after repeated injection of glycosylated proteins, lancet 1980;vol ii:738-740